Latest News & Updates
Breaking News
14 hours ago
Vaibhavi M.
Other trending news you may like to read
Novo Nordisk Secures FDA Approval For Awiqli®, First Once-Weekly Basal Insulin For Type 2 Diabetes
Novo Nordisk secures FDA approval for Awiqli (insulin icodec-abae), a once-weekly basal insulin for adults with type 2 diabetes, showing HbA1c reduction in Phase 3 ONWARDS trials.
Vaibhavi M.
Circio And United Immunity Collaborate To Advance In Vivo CAR-M Therapy Using Circular RNA Technology
Circio Holding ASA collaborates with United Immunity to evaluate circVec circular RNA with P-LNP delivery for in vivo CAR-M therapy targeting cancer, fibrosis, and autoimmune diseases.
Vaibhavi M.
Artelo Biosciences Expands ART27.13 Into GLP-1 Therapy Market For Muscle Preservation, Backed by Trials And New Patent
Artelo expands ART27.13 into GLP-1 therapy market for muscle preservation, supported by CAReS trial data and a new patent targeting muscle loss in metabolic and obesity treatments.
Vaibhavi M.
Oragenics Issues Regulatory Notice On Audit Opinion Highlighting Going Concern Risk
Oragenics reports going concern warning in FY2025 audit, disclosed under NYSE rules, highlighting financial risk while confirming no changes to previously filed financial statements.
Vaibhavi M.
